Progresive spastic paraparesis associated to HTLV-I in Chile;Paraparesia espástica progresiva asociada a HTLV-I en Chile: Estudio y seguimiento de 121 pacientes por diez años

Revista Chilena de Neuro-Psiquiatria

Volumn 47, Issue 1, 2009, Pages 50-66

  Cartier R , Luis ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Axoplasmic transport; Central axonopathy; HTLV I; Tropical Spastic Paraparesis

Indexed keywords

EID: 69249120522     PISSN: 00347388     EISSN: 07179227     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Poiesz B J, Ruscetti F W, Gazdar A F, Bunn P A, Minna J D, Gallo R C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 1980; 77 (12): 7415-7419.
2. Gessain A. Barin F, Vernant J C, Gout O, Calender A, De The G. Antibodies to Human T-lymphotropic Virus in patients with tropical spastic paraparesis Lancet 1985; U: 407-410.
3. Cartier L, Mora, Araya E, Castillo J L, Verdugo R, et al. HTLV-l Positive spastic paraparesis in a temperate zone. Lancet 1989; 1: 556-560.
4. Vásquez P, Sánchez G, Volante C, et al. Human T lymphotropic virus type 1: New risk for Chilean population. Blood 1991; 78: 850-851.
5. Cartier L, Cartier E. HTLV-l-ll in Chile, in HTLV, Truths and questions. Edt. Zaninovic V., Cali Colombia 1996; 150-158.
6. Cartier L, Tajima K, Araya F, Castillo J L, Zaninovic V, Hayami M, et al. Estudio preliminar de Seroprevalencia de HTLV-I en población Indígena Chilena. Rev Méd Chile 1993; 121: 241-246.
7. Miura T, Yamashita M, Zaninovic V, Cartier L, Takashima J, Igarashi T, et al. Molecular Phylogeny of Human T-cell Leukaemia virus type I and II of Amerindians in Colombia and Chile. J Molecular Evolution 1997; 44 (suppl 1): S76-S82.
8. Fujiyoshi T, Li H C, Lou H, et al. Characteristic distribution of HTLV Type 1 and HTLV Type II carriers among native ethnic groups in South America. AIDS Res and Human Retroviruses 1999; 15 (14): 1235-1239.
9. Cartier L. Epidemiología de la infección por HTTLV-I/HTLV-II en el continente americano. En: Retrovirus linfotropos humanos: Aspectos epidemiológicos y clínicos de la infección por HTLV-I/II. Editores: Calderón E, Matutes E, Soriano V.- ENE. Madrid 1998; 3: 41-46.
10. Li H C, Fujiyoshi T, Lou H, Yashiki S, Sonoda S, Cartier L, et al. The presence of ancient human Tcell Lymphotropic virus type I provirus DNA in an Andean mummy. Nature Medicine 1999; 12: 1428- 32
11. Ramírez E, Cartier L, Villota C, Fernández J. Genetic characterization and phylogeny of human T-cell lymphotropic virus type I from Chile. Virus Research 2002; 84v1-2: 135-49.
12. De Castro Costa C M, Goubau P, Liu H F, et al. HTLV-Negative and HTLV type 1-Positive tropical spastic paraparesis in North-eastern Brazil AIDS research and H. Retroviruses 1995; 11 (2): 315-318.
13. Gracia F, Castillo L C, Larreategui M, Roberts B, Cerdeño V, Heneine W, et al. Relation between Human T-Lymphotropic virus type I and neurological disease in Panama 1985-1990. AIDS Research and Human Retroviruses 1995; 1-6.
14. Cartier L, Vergara C, Ramírez E, Casivar T, Vásquez S. Seroprevalencia del HTLV-I en familiares de pacientes con paraparesias espásticas. Rev Méd Chile 1995; 123: 7-11.
15. Cartier L, Ramírez E, Galeno H. Familial form of tropical spastic paraparesis report of four families. Rev Méd Chile 1998; 126: 419-426.
16. Osame M, Janssen R, Kubota H, et al. Nationwide survey of HTLV-I associated myelopathy in Japan: Association with blood transfusion. Ann Neurol 1990; 28: 50-56.
17. Arango C, Concha M, Zaninovic V. Epidemiology of tropical spastic paraparesis. Ann Neurol 1988; 23 (suppl 1): 161-165.
18. Zaninovic V, Sanzón F, López F. Geographic independence of HTLV-I and HTLV-II foci in the Andes Highland, the Atlantic coast and the Orinoco Colombia. AIDS Res. Human Retroviruses 1993; 10: 97-101. (Pubitemid 24047400)
19. Takezaki T, Tajima K. Epidemiology of ATLL and HAM/TSP in Asia; HTLV-l in Truths and questions. Ed. Zaninovic U. Cali-Colombia 1996; 66-77.
20. Souther S O, Souther P J. Persistent HTLV-I infection of breast luminal epithelial cells. A role in HTLV-I transmission. Virology 1998; 241: 200-214.
21. Galeno H, Ramírez E, Cartier L. HTLV-I Provirus in seronegative Chilean patients with tropical spastic paraparesis. Lancet 1996; 348: 1170.
22. Ramírez E, Cartier L, Ríos M, Fernández J. Defective human T cell Iymphotropic virus type 1 (HTLV-l) Provirus in seronegative patients with tropical spastic paraparesis or HTLV-I myelopathy. J Clinical Microbiology 1 998; 36: 1811-1813.
23. Cartier L, Ramírez E, Galeno H. El gen "tax" del virus linfotrópico humano tipo I en la identificación etiológica de la paraparesia espástica tropical: Estudio clínico, serológico y de polimerasa en cadena en 72 pacientes. Rev Méd Chile 1999; 127: 945-952.
24. Nakagawa M, Izumo S, ljichi S, et al. HTLV-I associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings. Journal of neurovirology 1995; 1: 50-61.
25. Gout O, Baulac M, Gessain A, et al. Rapid development of myelopathy after HTLV-I ¡infection acquired by transfusion during cardiac transplantation. N England J of Med 1990; 322 (8): 383-388.
26. Cruickshank J K, Rudge P, Dalgleish A G, Newton M, Mc Lean, et al. Tropical spastic paraparesis and human T-cell lymphotropic virus type 1 in the United Kingdom Brain 1989; 112: 1057-1090.
27. Castillo J L, Cartier L, Araya F, Verdugo R, Mora C, Gibb C. Evoked potential abnormalities in progressive spastic paraparesis associated to HTLVI. Acta Neurol Scand 1991; 83: 151-154.
28. Said G, Lacroix C, Fujimura H, et al. The Peripheral Neuropathy of Necrotizing Arteritis: A Clinopathological Study Ann Neurol 1988; 23: 461-465.
29. Sugimura K, Takahashi A, Watanabe M, et al. Demyelinating changes in sural nerve biopsy of patients with HTLV-l-associated myelopathy. Neurology 1 990; 40: 1263-1266.
30. Bhijee A L, Biel P L, Wiley C A, Windsor I M, Matthias D A, Amenomori T, et al. Peripheral nerve lesions in HTLV-I associated myelopathy. (HAM/TSP). Muscle Nerve 1993; 16: 21-26.
31. Cervilla J, Cartier L, García L. Resonancia magnética de médula espinal y cerebro en el correlato clínico de la paraparesia espástica progresiva que se asocia al virus humano linfotrópico tipo I. Rev Méd Chile 2006; 134: 1010-1018.
32. Kira J, Fujihara K, Itoyama Y, Goto I, Hasuo K. Leukoencephalopathy in HTLV-I associated myelopathy/tropical spastic paraparesis MRI analysis and a tow year follow up study after corticosteroid therapy. J. Neurol Sciences 1991; 160: 41-49.
33. Ferraz A C, Gabbai A A, Abdala N, Gomes R. Ressonancia Magnética na mielopatia associada ao HTLV-I Leucoencefalopatia e atrofia medular. Arq Neuropsiquiatr 1997; 55: 728-736.
34. Stevenson V L, Miller D H, Rovaris M, Barkhof F, Brochet B, Dousset V, et al. Primary and transitional progressive MS. A clinical and MRI crosssectional study. Neurology 1999; 52: 839-845.
35. Umehara F, Nose H, Saito M, Fukuda M, Ogino M, Toyota T, et al. Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy. Journal of NeuroVirology 2007; 13: 260-267.
36. Ogata A, Nagashima K, Tashiro K, Miyakawa A, Mikuni C. MRI pathological correlate of brain lesions in a necropsy case of HTLV-I associated myelopathy. J Neurol Neurosurg Psychiatry 1993; 56: 194-196.
37. Lycke J, Svennerholm B, Svenningsson A. Pssjble assocjation of HTLV-I infection and dementia. Acta Neurol Scand 1993; 88: 199-203.
38. Cartier L, Gormáz A, Kleinsteuber K, Ramírez E, Galeno H. New form of subcortical dementia: encephalopathy due to infection with human lymphotropic T virus (HTLV-I). Rev Méd Chile 1997; 125 (2): 209-213.
39. Cartier L, Gormaz A. Demencia subcortical en paraparesia espástica tropical asociada a HTLV-I: Estudio de 43 casos. Rev Méd Chile 1999; 127: 444-450.
40. Silva MTT, Matos P, Alfaro A, Araujo AQ-C. Neuropsychological assessment in HTLV-1 infection: A comparative study among TSP/HAM, asymptomatic carriers, and healthy controls. J Neurol Neurosourg Psychiatry. 2003; 74: 1085-1089.
41. Souther S O, Souther P J. Persistent HTLV-I infection of breast luminal epithelial cells: A role in HTLV transmission. Virology 1998; 241: 200-214.
42. Cartier L, Castillo J L, Cea J G, Villagra R. Chronic dacrosyalpadenitis in HTLV-l associated myelopathy. J Neurol Neurosurg Psychiatry 1995; 58: 244-246.
43. Vernant J C, Buison G, Magdeleiene J, De Thore J, Jonannelle A, Neisson-Vernant C, et al. Tlymphocyte alveolitis, Tropical spastic paraparesis and Sjögren syndrome. Lancet 1988; i: 177.
44. Green J E, Hinrichs S H, Vogel J, Jay G. Exocrinopathy resembling Sjögren's syndrome in HTLV- 1 tax transgenic mice. Nature 1989; 34: 72-74.
45. Cartier L, Vergara C, Ramírez E. Proteína Tax (HTLV-I) probable factor patogénico y marcador del síndrome sicca que se asocia al HAM/TSP. Rev Méd Chile 2005; 133: 1183-1190.
46. Beby-Defaux A, Frugier E, Bourgoin A, et al. Nucleotide sequence analysis of human T-Cell lymphotropic virus type 1 pX anci LTR regions from patients with sicca syndrome. J of Med Virology 1999; 59: 245-255.
47. Ijichi T, Miyata K, Man S, Tsuchihashi Y. Asymptomatic primary biliary cirrhosis in HTLVl associated myelopathy. Am J Gastroenterology 1993; 88 (12): 21 07-9.
48. Caudec L, Cauberrere I, Venet A. Alveolite lymphocytair et myelopathie assocIee au virus HTLV-I. Retrovirus 1990; 6: 109-113.
49. Higashiyamu Y, Katamine S, Kolmo S. Expression of Human T Lymphotropic virus type I (HTLV-I) tax/rex gene in fresh brocho- alveolar lavage cells of HTLV-I infected individuals. Clin Exp Inmunol 1994; 96: 193-201.
50. Cartier L, Prina L. Polymyositis associated to HTLV-l infection. Rev Méd Chile 1996; 124: 461-464.
51. Sherman M, Amin R, Rodegers-Johnson P, et al. ldentification of human T cell leukemiallymphoma virus type l antibodies, DNA protein in patients with polymyositis. Arthritis & Rheumatism 1995; 5: 690-698.
52. Smadja D, Bellance R, Cabre P, et al. Atteintes du systéme nerveux périphérique et du muscle squelettiqüe au cours des paraplégies associées au virus HTLV-I. Rev Neurol 1995; 151(3): 190-195.
53. Higushi L, Hashimoto K, Kashio N, et al. Detection of HTLV-I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis. Muscle & Nerve 1995; 18: 854-858.
54. Lwasaki Y. Pathology of chronic myelopathy associated with HTLV-l infection (HAM/TSP) J. Neurol Scien 1990; 96: 103-123.
55. Jacobson S, Zaninovic V, Mora C, et al. lmmunological findings in neurological diseases associated with antibodies to HTLV-I: Activated lymphocytes in tropical spastic paraparesis. Ann Neurol 1988; 23: S196-S200.
56. Umehara F, Izumo S, Ronquillo A T, Matsumuro K, Sato E, Osame M. Cytokine expression in the spinal cord lessions in HTLV-l associated myelopathy J.Neuropathol Exp Neurol 1994; 53: 72-77.
57. Umehara F, Izumo S, Nakagawa M, Ronquillo A T, Takahashi K, Matsumuro K, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lessions in HTLV-l associated myelopathy. J Neuropathol Exp Neurol 1993; 52: 424-430.
58. Umehara E, Izumo S, Takeya M, et al. Expression of adhesion molecules and monocyte chemoattractant protein-1 (MCP 1 in the spinal cord lesions in HTLV-l associated myelopathy. Acta Neuropathol 1996; 91: 343-350.
59. Afonso P V, Ozden S, Cumont M C, Seilhean D, Cartier L, Payam R, et al. Alteration of Blood- Brain Barrier integrity by retroviral infection. Plos Pathogens 2008; 4: 1-11.
60. Tangy F, Vernant J C, Coscoy L, Ossondo M, Ballance R, Zaninovic V, et al. A search for Human T-Cell leukemia virus type I in the lesions of patients with tropical spastic paraparesis and polymiositis. Ann Neurol 1995; 38: 454-460.
61. Boxus M, Twizere J C, Legros S, Dewulf J F, Kettmann R, Willems L. The HTLV-I Tax interactome. Retrovirology 2008 ; 5: 76: 1-24.
62. Reddy T R, Li X, Jones Y, Ellisman M H, Ching G Y, Liem R K, et al. Specific interaction of HTLV Tax protein and human type IV neuronal intermediate filament protein. Proc Natl Acad Sci USA 1998; 95: 702-707.
63. Maldonado H, Ortiz-Riaño E, Krause B, Barriga A, Medina F, Pando M E, et al. Microtubule proteins and their posttranslationally forms in cerebrospinal fluid of patients with paraparesis associated to HTLV-I infection and in SH-SY5Y cells, and in vitro model of HTLV-I induced disease. Biol Res 2008; 41: 239-252.
64. Cartier L, Ramírez E. Presence of HTLV-I Tax protein in cerebrospinal fluid from HAM/TSP patients. Archives Virol 2005; 150: 743-753.
65. Ramírez E, Cartier L, Torres M, Barría M. Temporary dynamics of human t-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human Tlymphotropic virus type I-associated myelopathy patients. J Med Virol 2007; 79: 782-790.
66. Giraudon R, Szymocha R, Buart S, Bernard A, Cartier L, Belin M F, et al. T Lymphocytes activated by persistent viral infection differentially Modify the Expression of metalloproteinases (MMPS) and their endogenous inhibitors, TIMPs, in Human Astrocytes: relevance to HTLV-I induced neurological disease. Journal of Immunology 2000; 164: 2718-2727.
67. Valenzuela M A, Collados L, Kettlun A M, González R, Cartier L. Increased activity of matrix metalloproteinases and their tissue inhibitors in cerebrospinal fluid of patients with HTLV-I associated tropical spastic paraparesis. Rev Méd Chile 2000; 128: 585-592.